The bivalent HPV (human papillomavirus) vaccine is suitable for women aged 9 to 45. The bivalent HPV vaccine covers HPV 16 and HPV 18 high-risk viruses, which according to research data are responsible for most cervical cancers. Therefore, for women between the ages of 9 and 45, the bivalent HPV vaccine can be used to prevent HPV infections and to reduce the likelihood of suffering from cervical cancers as well as warts and other diseases. The bivalent HPV vaccine needs to be given in 3 doses, respectively in the 0th, 1st and 6th month, and will only be effective after three doses. If you are sexually active, you will have to undergo HPV and TCT tests before vaccination, and the results will be free of abnormalities before you can be vaccinated. HPV vaccination is not recommended for women who are already infected with HPV. The bivalent HPV vaccine is suitable for women between the ages of 9 and 45. If you want to receive the bivalent HPV vaccine, you need to make an appointment at your local hospital.